Trial Profile
A two-period cross-over study assessing Impact of Meal Timing on Eravacycline Exposure During the Oral Portion of an IV to Oral Transition Dosing Regimen
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Oct 2017
Price :
$35
*
At a glance
- Drugs Eravacycline (Primary) ; Eravacycline (Primary)
- Indications Intra-abdominal infections; Respiratory tract infections; Urinary tract infections
- Focus Pharmacokinetics
- 23 Oct 2017 New trial record
- 08 Oct 2017 Results presented at the IDWeek 2017